GE HealthCare Technologies Inc.

GEHC Healthcare Medical Devices

GE HealthCare Technologies Inc.’s revenue for fiscal 2025 (year ended December 2025) was $20.6 billion, up 4.84% from fiscal 2024.

Revenue
+7.19%
EPS
+40.6%
Free cash flow
+64.2%
Total debt
−1.90%

Quarter to September 2026, against a year earlier

82.39 1.36 −1.62%
Market cap
$37.9B
P/E
17.5×
Fwd P/E
15.5×
Dividend yield
0.17%
F-score
4/9
Altman Z
1.96
Beneish M
−2.33
Dividend safety
74/100

GE HealthCare Technologies Inc. 10-Q filed Apr 29, 2026

Fiscal Q1 2026 · Period ended Mar 31, 2026 · Filed · accepted 6:26 AM ET · Document on sec.gov · Filing index

What changed

Part I, Item 2, Management’s Discussion and Analysis, against the 10-Q filed Oct 29, 2025: 14 added · 37 removed · 43 modified; 15 with only figures updated

  1. Modified

    The following discussion and analysis of our financial results should be read in conjunction with the condensed consolidated financial statements and corresponding notes (the “financial statements”) included elsewhere in this Quarterly Report on Form 10-Q. The following discussion and analysis provide information management believes to be relevant to understanding the financial results of GE HealthCare Technologies Inc. and its subsidiaries (“GE HealthCare,” the “Company,” “our,” “us,” or “we”) for the three and nine months ended September 30March 31, 20252026 and 20242025. For a full understanding of our financial condition and results of operations, the below discussion should be read alongside the Management’s Discussion and Analysis of Financial Condition and Results of Operations included in our Annual Report on Form 10-K for the fiscal year ended December 31, 20242025. This discussion contains forward-looking statements that are based upon current expectations and are subject to uncertainty and changes in circumstances; see “Forward-Looking Statements.” Our actual results could differ materially from the results contemplated by these forward-looking statements due to a number of factors, including those discussed below and elsewhere in this Quarterly Report on Form 10-Q, and particularly in Item 1A, “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended December 31, 20242025.